List of Cancer Advances patents | 7 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8158128 Monoclonal antibodies to progastrin	Patent 8158128 was granted and assigned to Cancer Advances on April, 2012 by the United States Patent and Trademark Office.		‌ Cancer Advances	United States Patent and Trademark Office	8158128	April 17, 2012
‌ US Patent 11583576 Compositions and methods for inducing humoral and cellular immunities against tumors and cancer	Patent 11583576 was granted and assigned to Cancer Advances on February, 2023 by the United States Patent and Trademark Office.	‌ Cancer Advances	‌ Cancer Advances	United States Patent and Trademark Office	11583576	February 21, 2023
‌ US Patent 8343930 Combination therapy for the treatment of tumors	Patent 8343930 was granted and assigned to Cancer Advances on January, 2013 by the United States Patent and Trademark Office.		‌ Cancer Advances	United States Patent and Trademark Office	8343930	January 1, 2013
‌ US Patent 8388966 Combination treatment of pancreatic cancer	Patent 8388966 was granted and assigned to Cancer Advances on March, 2013 by the United States Patent and Trademark Office.		‌ Cancer Advances	United States Patent and Trademark Office	8388966	March 5, 2013
‌ US Patent 7964371 Gastrin hormone immunoassays	Patent 7964371 was granted and assigned to Cancer Advances on June, 2011 by the United States Patent and Trademark Office.		‌ Cancer Advances	United States Patent and Trademark Office	7964371	June 21, 2011
‌ US Patent 8808695 Monoclonal antibodies to progastrin	Patent 8808695 was granted and assigned to Cancer Advances on August, 2014 by the United States Patent and Trademark Office.		‌ Cancer Advances	United States Patent and Trademark Office	8808695	August 19, 2014
‌ US Patent 12076383 Compositions and methods for inducing humoral and cellular immunities against tumors and cancer	Patent 12076383 was granted and assigned to Cancer Advances on September, 2024 by the United States Patent and Trademark Office.	‌ Cancer Advances	‌ Cancer Advances	United States Patent and Trademark Office	12076383	September 3, 2024